Arcutis Biotherapeutics Inc. — ZORYVE (roflumilast) Cream 0.3% · Plaque Psoriasis in Children Ages 2 to 5.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (1/13/26) through T+5. Run-up high $29.88 on 1/15/26, low $19.5 on 5/21/26 (T-120 to T-1). FDA decision 6/30/26. Historical price action, not a forecast.